Healthcare Companies Beat Q3 EPS Estimates at a 96% Rate
Photo: TokenPost
In the 23-company tally, 22 companies beat EPS estimates and 21 beat revenue estimates; all 23 posted year-over-year revenue growth. Sixteen companies, or 70%, had higher earnings than a year earlier. Revenue beat estimates at 21 companies, or 91%, even as every company in the tally recorded year-over-year revenue growth. Eli Lilly had the strongest revenue growth among the companies highlighted, at 39%, and raised its fiscal 2026 revenue outlook. Regeneron’s revenue increased 36%. AbbVie, Gilead, Biogen and Illumina also raised parts of their fiscal 2026 outlooks.
Source: TokenPost
